While there is a whole host of viruses going around, there are thankfully no new viruses to fret about—the ones we have are ...

Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.

Respiratory syncytial virus (RSV) is a common, highly contagious illness that affects the nose, throat, and lungs. Although RSV usually causes mild illness with cold-like symptoms, the infection ...

Vulnerable and elderly Australians are missing out on protection against respiratory syncytial virus (RSV) because many can’t afford to pay $350 for a one-off vaccine.

Alone and in combination with other lower respiratory tract disease signs and symptoms, dyspnea is the best predictor of severe RSV outcomes.

RSV is usually contagious for three to eight days. A patient also may be contagious a day or two before experiencing symptoms ...

The Cyprus pulmonology society on Thursday urged Health Minister Michael Damianos to approve a respiratory syncytial virus (RSV) vaccine for use Cyprus. The society also seeks its inclusion into the ...

Respiratory syncytial virus, commonly referred to as RSV, infects the nose, throat and lungs, according to the CDC. The virus can spread in several ways, including through an infected person's ...

RSV is a common respiratory virus that causes mild, cold-like symptoms in healthy adults. Like similar viruses, it infects the nose, throat and lungs, making it difficult to tell apart from other ...

Influenza A, COVID-19 and norovirus (stomach flu) are on the rise, according to the Centers for Disease Control and ...

Respiratory syncytial virus, or RSV, is a common respiratory virus that infects the nose, throat, and lungs and acts a lot like a common cold or mild flu, according to the CDC. It tends to spread ...

Dr. Ben Weston, chief health policy advisor for Milwaukee County, joins Lake Effect's Joy Powers to talk about how you can ...